Back to results
US 2017/0246159 A1Published application
Benzoquinolone inhibitors of vmat2
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Manouchehr Shahbaz, Chengzhi Zhang
Life of this patent
Estimating the term…
Abstract
The present invention relates to new benzoquinolone inhibitors of VMAT2, pharmaceutical compositions thereof, and methods of use thereof.
Claims25
A long acting pharmaceutical formulation comprising a therapeutically effective amount of a compound of Formula
- or a salt or stereoisomer thereof,
- wherein each position represented as D has deuterium enrichment of no less than about 10%.
Dependencies are inferred from the claim text.